CASI Pharmaceuticals
CASI
CASI
52 hedge funds and large institutions have $32.9M invested in CASI Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 15 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
28% less capital invested
Capital invested by funds: $45.9M → $32.9M (-$13M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
52
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$335K | |
| 2 | +$145K | |
| 3 | +$132K | |
| 4 |
Renaissance Technologies
New York
|
+$120K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$113K |
Top Sellers
| 1 | -$284K | |
| 2 | -$242K | |
| 3 | -$210K | |
| 4 |
MIM
MetLife Investment Management
Whippany,
New Jersey
|
-$106K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$91K |